In-hospital mortality | Duration of ICU≧7 days | Massive transfusionb | Complication | |||||
---|---|---|---|---|---|---|---|---|
Odds ratio(95%CI) | p univariate analysis | Odds ratio(95%CI) | p univariate analysis | Odds ratio(95%CI) | p univariate analysis | Odds ratio(95%CI) | p univariate analysis | |
Age | 1.05 (0.89–1.01) | 0.05 | 1.00 (0.79–1.02) | 0.83 | 0.99 (0.98–1.04) | 0.61 | 0.99 (0.98–1.04) | 0.33 |
Sex female | 1.28 (0.12–13.41) | 0.84 | 1.99 (0.54–7.37) | 0.29 | 0.90 (0.24–3.41) | 0.88 | 0.59 (0.16–2.19) | 0.42 |
Severe liver injury (gradeIV,V) | 1.42 (0.19–10.77) | 0.74 | 1.20 (0.43–3.32) | 0.73 | 1.19 (0.39–3.66) | 0.76 | 6.61 (2.14–20.40) | < 0.01 |
sBP (arrival) | 1.04 (0.92–1.01) | 0.09 | 0.99 (0.99–1.03) | 0.19 | 0.97 (1.01–1.06) | < 0.01 | 0.99 (00.99–1.03) | 0.22 |
RR (arrival) | 0.91 (0.91–1.31) | 0.33 | 1.06 (0.86–1.03) | 0.16 | 1.05 (0.87–1.05) | 0.32 | 1.00 (0.92–1.09) | 0.98 |
GCS (arrival) | 0.65 (1.13–2.09) | < 0.01 | 0.83 (0.99–1.47) | 0.04 | 0.79 (1.05–1.54) | 0.01 | 0.99 (0.85–1.20) | 0.90 |
Base Excess (arrival) | 0.97 (0.78–1.37) | 0.81 | 0.77 (1.09–1.55) | < 0.01 | 0.84 (1.02–1.39) | 0.02 | 1.00 (0.87–1.14) | 0.99 |
Fibrinogen (arrival) | 1.00 (0.99–1.01) | 0.86 | 1.00 (0.998–1.01) | 0.11 | 0.99 (1.00–1.02) | 0.01 | 1.00 (0.99–1.00) | 0.84 |
ISS | 1.05 (0.90–1.02) | 0.19 | 1.08 (0.88–0.98) | < 0.01 | 1.18 (0.77–0.93) | < 0.01 | 0.99 (0.97–1.05) | 0.57 |
Time from Door to start OM/TAE | 0.98 (0.98–1.07) | 0.19 | 1.01 (0.98–1.00) | 0.09 | 1.01 (0.98–1.00) | 0.28 | 1.00 (0.99–1.01) | 0.84 |
Time for OM/TAE | 0.97 (0.97–1.10) | 0.13 | 1.01 (0.98–1.00) | 0.06 | 1.00 (0.98–1.01) | 0.44 | 0.99 (0.99–1.02) | 0.24 |
Hemodynamicaly unstablea | 1.90 (0.25–14.52) | 0.54 | 7.03 (2.19–22.59) | < 0.01 | 15.8 (4.08–60.74) | < 0.01 | 0.96 (0.33–2.78) | 0.94 |
TAE | 0.41 (0.04–4.53) | 0.50 | 0.08 (0.00–0.73) | < 0.01 | 0.10 (0.02–0.53) | < 0.01 | 2.23 (0.41–12.05) | 0.33 |